Gradian Diagnostics is a holding company focused on developing Next Gen medical and diagnostics technologies that effectively tackle healthcare needs and have a real potential for exponential growth. At Gradian Dx we understand that success in the complex healthcare environment is not only defined by the ability to develop the latest medical innovation. Making the right strategic choices, together with timing and the appropriate financing capabilities are key factors that define the success of new medical technologies in the market place. Our founders and advisors share a deep passion for healthcare and have a wealth of managerial and financing expertise, both a fundamental part of the company’s DNA. It is these competitive advantages that allow the company not only to select the right technology to leverage its portfolio, but also to successfully develop a market for each product that will allow to generate higher returns. Our philosophy is to take a practical approach towards developing our portfolio. We believe inspiration must always be backed up by a heavy dose of quantitative evidence and apply hard nosed management fundamentals to ensure science actually turns into commercially successful products that make a difference in the lives of patients.